Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Adamas Pharmaceuticals, Inc. News

5 Top Stock Gainers for Monday: Aspen, SoFi, Flexion Therapeutics

Aspen Technology, Sofi Technologies, Flexion Therapeutics, Adamas Pharmaceuticals and Ocular Therapeutix are five top stock gainers for Monday.

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.

Adamas Skyrockets on FDA Approval for Dyskinesia Treatment - Biotech Movers

The Emeryville, Calif.-based firm secures FDA approval for Gocovri as a treatment for dyskinesia in Parkinson's disease patients.

Hurricane Harvey, Now a Category 2, Heads for Oil-Rich Gulf Coast

Hurricane Harvey was upgraded to a category 2 storm overnight and could be a category 3 before the day is over.

Biotech's are quite active Tuesday. Find Out who's moving and why:

Biogen's new spine disease drug outperformed expectations during its commercial debut.

Breaking News

Donald Trump Media SPAC Digital World Acquisition Gets Subpoenas Linked To Grand Jury Probe

"These subpoenas ... could materially delay, materially impede, or prevent" DWAC's planned merger with Trump Media & Technology Group.

General Electric Stock Gains As CEO Larry Culp Takes Over Aviation Division

"There is tremendous opportunity in aviation over the coming years, and the Board and I decided it is the right time for me to take on this expanded role," said GE CEO Larry Culp.

Barstool's Portnoy Takes a Surprising Stand on a Key Political Issue

The outspoken Republican with a platform voices his opinion on the state of democracy moving to the right.

McDonald's Brings Back a Classic Menu Item (with a Catch)

You never know what the fast-food chain might bring back or create a new version of.